Strikingly, and showing marker potential for disease progression and outcome, high plasma resistin levels of non-critically ill COVID-19 patients were characteristic for those patients that progressed to severe illness and were less likely to survive the COVID-19 disease [76]. This evidence concerns the gene RETN and COVID-19.